| 英文名稱 | Benzoylhypacoitine |
|---|---|
| 中文名稱 | 苯甲酰次烏頭原堿/苯甲酰海帕烏頭原堿/苯甲酰次烏頭堿 |
| CAS號(hào) | 63238-66-4 |
| 分子式 | C31H43NO9 |
| 分子量 | 573.67 |
| 外觀 | 白色粉末 |
| 沸點(diǎn) | 663.6±55.0 °C | Condition: Press: 760 Torr |
| 酸度系數(shù)pKa | 12.07±0.70 | Condition: Most Acidic Temp: 25 °C |
| 英文名稱 | Benzoylhypacoitine |
|---|---|
| 中文名稱 | 苯甲酰次烏頭原堿/苯甲酰海帕烏頭原堿/苯甲酰次烏頭堿 |
| CAS號(hào) | 63238-66-4 |
| 分子式 | C31H43NO9 |
| 分子量 | 573.67 |
| 外觀 | 白色粉末 |
| 沸點(diǎn) | 663.6±55.0 °C | Condition: Press: 760 Torr |
| 酸度系數(shù)pKa | 12.07±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000082
中文名稱：苯甲酰次烏頭原堿
中文別名：苯甲酰海帕烏頭原堿；苯甲酰次烏頭堿
英文名稱：Benzoylhypacoitine
英文別名：11aH-12,3,6a-Ethanylylidene-7,9-methanonaphth[2,3-b]azocine, aconitane-8,13,14,15-tetrol deriv.;14-O-Benzoylhypaconine;3-Deoxymesaconine 14-benzoate;Benzoylhypacoitine;Benzoylhypaconine;Hypaconine 14-benzoate;
分子式：C31H43NO9
分子量：573.67
CAS號(hào)：63238-66-4
純度：HPLC≥98%
沸點(diǎn)：663.6±55.0 °C | Condition: Press: 760 Torr
密度：1.37±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)：12.07±0.70 | Condition: Most Acidic Temp: 25 °C
儲(chǔ)存條件：-20℃，干燥、避光、密封
規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶需求包裝
供應(yīng)單位：四川省維克奇生物科技有限公司
供應(yīng)電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類標(biāo)準(zhǔn)品和天然植物有效單體，主打中藥對(duì)照品/標(biāo)準(zhǔn)品/天然植物有效單體，化學(xué)合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請(qǐng)關(guān)注！ 新批次有現(xiàn)貨，歡迎咨詢。
| Components and Pharmacodynamical Mechanism of Yinfupian Based on Liquid Chromatography-Mass Spectrometry and Proteomics Analyses | ||
| 來源：SCI：Frontiers in Pharmacology | 作者：Tong Heng-li | 備注：影響因子：5.811 |
| 引用描述 | ||
Standard solution: All standards (Weikeqi biotech Co., Ltd., Chengdu, China) were weighed and added isopropanol-dichloromethane (1:1) mixed solution to prepare solution contained 10.32 μg/ml aconitine (Batch NO. 130723), 37.38 μg/ml mesaconitine (Batch NO.130402), 5.75 μg/ml hypaconitine (Batch NO. 130509), 33.34 μg/ml benzoylaconine (Batch NO. 130516), 7.92 μg/ml benzoylmesaconine (Batch NO. 130505), and 5.38 μg/ml benzoylhypaconine (Batch NO. 130401). | ||
| Material Basis of Chinese Herbal Formulas Explored by Combining Pharmacokinetics with Network Pharmacology | ||
| 來源：SCI：PLoS One | 作者：Lixia Pei | 備注：影響因子：3.73 |
| 引用描述 | ||
Fifteen standard compounds (psoralen, isopsoralen, corylifolin, corylifolinin, psoralidin, xanthotoxin, bergapten, osthole, imperatorin, aconitine, hypaconitine, mesaconitine, benzoylaconine, benzoylhypaconine, and benzoylmesaconitine; Figure 1), were purchased from Weikeqi Biological Technology Co., Ltd. (Chengdu, China). The purities of the compounds were >98% as determined by high-performance liquid chromatography (HPLC). The stock solution of each standard was prepared at a concentration of 1 mg/mL in 50% MeOH and stored at ?80°C until use. | ||
| The influence of compatibility of Si-Ni decoction with metabolism in intestinal bacteria on transports of toxic diterpenoid alkaloids from processed aconite root across Caco-2 monolayers | ||
| 來源：SCI：JOURNAL OF ETHNOPHARMACOLOGY | 作者：Min Zhang | 備注：影響因子：3.115 |
| 引用描述 | ||
14-O-benzoylmesaconine (PubChem CID 24832659), 14-O-benzoylaconine (PubChem CID 20055771) and 14-O-benzoylhypaconine (PubChem CID 78358526), liquiritin apioside (PubChem CID 10076238), liquiritin (PubChem CID 503737), liquiritigenin (PubChem CID 114829), isoliquiritin apioside (PubChem CID 6442433), isoliquiritin (PubChem CID 5318591), isoliquiritigenin (PubChem CID 638278), glycyrrhizic acid (PubChem CID 14982) and glycyrrhetic acid (PubChem CID 3230) were purchased from Chengdu Weikeqi Biological Technology Co., Ltd. (Chengdu, Sichuan, China). Hypaconitine (PubChem CID 441737), atenolol (PubChem CID 2249) and propranolol hydrochloride (PubChem CID 62882) were purchased from Dalian Meilun Biological Technology Co., Ltd. | ||
| Human intestine and liver microsomal metabolic differences between C19-diester and monoester diterpenoid alkaloids from the roots of Aconitum carmichaelii Debx. | ||
| 來源：SCI：TOXICOLOGY IN VITRO | 作者：Min Zhang | 備注：影響因子：2.866 |
| 引用描述 | ||
BAC, BMA and BHA (purity > 98%) were purchased from Weikeqi Biotechnology Co., Ltd. (Chengdu, Sichuan, China). AC, MA and HA (purity > 98%) were purchased from Meilun Biotechnology Co., Ltd. | ||
